Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$10.58 USD
-0.07 (-0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $10.57 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Avid Bioservices, Inc falls in the month of April.
All items in Millions except Per Share data.
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 38 | 39 | 126 | 170 | 36 |
Receivables | 17 | 18 | 21 | 19 | 9 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | 30 | 44 | 26 | 12 | 11 |
Other Current Assets | 19 | 12 | 7 | 7 | 4 |
Total Current Assets | 104 | 112 | 180 | 208 | 60 |
Net Property & Equipment | 187 | 177 | 93 | 37 | 27 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 114 | 115 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 5 | 5 | 5 | 2 | 1 |
Total Assets | 337 | 451 | 430 | 266 | 108 |
Liabilities & Shareholders Equity | 4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 4 |
Accounts Payable | 21 | 25 | 10 | 9 | 6 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | 5 | 9 | 8 | 9 | 3 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | 43 | 39 | 55 | 52 | 30 |
Total Current Liabilities | 71 | 74 | 76 | 71 | 44 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 154 | 141 | 140 | 97 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 7 | 2 | 2 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | 276 | 262 | 255 | 188 | 66 |
Shareholders Equity | 4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 633 | 620 | 606 | 638 | 613 |
Retained Earnings | -572 | -431 | -431 | -560 | -571 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 61 | 189 | 175 | 78 | 42 |
Total Liabilities & Shareholder's Equity | 337 | 451 | 430 | 266 | 108 |
Total Common Equity | 100,060 | 189 | 175 | 78 | 42 |
Shares Outstanding | 63.40 | 62.50 | 61.70 | 60.80 | 56.40 |
Book Value Per Share | 1,578.23 | 3.03 | 2.83 | 1.28 | 0.74 |
Fiscal Year End for Avid Bioservices, Inc falls in the month of April.
All items in Millions except Per Share data.
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,961 | 31 | 31 | 25 |
Receivables | NA | 17 | 19 | 13 | 16 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | 30 | 35 | 39 | 41 |
Other Current Assets | NA | 19 | 20 | 21 | 16 |
Total Current Assets | NA | 104 | 104 | 104 | 98 |
Net Property & Equipment | NA | 187 | 188 | 187 | 182 |
Investments & Advances | NA | NA | 0 | 0 | 0 |
Other Non-Current Assets | NA | NA | 0 | 0 | 0 |
Deferred Charges | NA | NA | 118 | 117 | 114 |
Intangibles | NA | NA | 0 | 0 | 0 |
Deposits & Other Assets | NA | 5 | 5 | 5 | 5 |
Total Assets | NA | 337 | 455 | 455 | 442 |
Liabilities & Shareholders Equity | 7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 141 | 0 | 0 |
Accounts Payable | NA | 21 | 20 | 23 | 23 |
Current Portion Long-Term Debt | NA | NA | 0 | 0 | 0 |
Current Portion Capital Leases | NA | NA | 0 | 0 | 0 |
Accrued Expenses | NA | 5 | 4 | 4 | 5 |
Income Taxes Payable | NA | NA | 0 | 0 | 0 |
Other Current Liabilities | NA | 43 | 57 | 49 | 35 |
Total Current Liabilities | NA | 71 | 223 | 77 | 64 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 154 | 0 | 141 | 141 |
Long-Term Debt | NA | NA | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 7 | 7 | 8 | 1 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | 276 | 275 | 271 | 252 |
Shareholders Equity | 7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 633 | 629 | 626 | 623 |
Retained Earnings | NA | -572 | -449 | -442 | -433 |
Other Equity | NA | NA | 0 | 0 | 0 |
Treasury Stock | NA | NA | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 61 | 180 | 184 | 191 |
Total Liabilities & Shareholder's Equity | NA | 337 | 455 | 455 | 442 |
Total Common Equity | 0 | 100,060 | 180 | 184 | 191 |
Shares Outstanding | 63.50 | 63.40 | 63.20 | 63.20 | 63.10 |
Book Value Per Share | 0.00 | 1,578.23 | 2.85 | 2.91 | 3.02 |